Zhejiang Yatai Pharmaceutical Co Ltd
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers solid dosage, cephalosporin powder injection, and freeze-dried powder injection products. It also provides various antibiotic and non-antibiotic drugs. The company was founded in 1989 and is based in Shaoxing, China.
Zhejiang Yatai Pharmaceutical Co Ltd (002370) - Total Liabilities
Latest total liabilities as of September 2025: CN¥92.77 Million CNY
Based on the latest financial reports, Zhejiang Yatai Pharmaceutical Co Ltd (002370) has total liabilities worth CN¥92.77 Million CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Yatai Pharmaceutical Co Ltd - Total Liabilities Trend (2006–2024)
This chart illustrates how Zhejiang Yatai Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Yatai Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Yatai Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yatsen Holding
NYSE:YSG
|
USA | $1.01 Billion |
|
Odine Solutions Teknoloji As
IS:ODINE
|
Turkey | TL424.54 Million |
|
Delong Composite Energy Group Co Ltd
SHE:000593
|
China | CN¥956.01 Million |
|
Aluar Aluminio Argentino
BA:ALUA
|
Argentina | AR$1.35 Trillion |
|
Neoen SA
PA:NEOEN
|
France | €5.92 Billion |
|
Vitrolife AB
ST:VITR
|
Sweden | Skr3.23 Billion |
|
INVENTURUS KNOWLEDGE SO L
NSE:IKS
|
India | ₹13.66 Billion |
Liability Composition Analysis (2006–2024)
This chart breaks down Zhejiang Yatai Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.08 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Yatai Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Yatai Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual total liabilities of Zhejiang Yatai Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥429.59 Million | -49.37% |
| 2023-12-31 | CN¥848.50 Million | -30.59% |
| 2022-12-31 | CN¥1.22 Billion | +3.79% |
| 2021-12-31 | CN¥1.18 Billion | -9.11% |
| 2020-12-31 | CN¥1.30 Billion | -20.75% |
| 2019-12-31 | CN¥1.64 Billion | +40.68% |
| 2018-12-31 | CN¥1.16 Billion | +104.07% |
| 2017-12-31 | CN¥569.62 Million | +114.39% |
| 2016-12-31 | CN¥265.69 Million | -79.04% |
| 2015-12-31 | CN¥1.27 Billion | +1152.60% |
| 2014-12-31 | CN¥101.21 Million | +9.97% |
| 2013-12-31 | CN¥92.04 Million | -19.32% |
| 2012-12-31 | CN¥114.08 Million | -9.81% |
| 2011-12-31 | CN¥126.48 Million | -12.78% |
| 2010-12-31 | CN¥145.02 Million | -31.62% |
| 2009-12-31 | CN¥212.08 Million | +0.59% |
| 2008-12-31 | CN¥210.84 Million | +3.10% |
| 2007-12-31 | CN¥204.51 Million | +15.44% |
| 2006-12-31 | CN¥177.15 Million | -- |